About IGM Biosciences, Inc.
IGM Biosciences (Nasdaq: IGMS) is a clinical-stage biotechnology company committed to developing and delivering a new class of medicines to treat patients with cancer and autoimmune and inflammatory diseases. The Company’s pipeline of clinical and preclinical assets is based on the IgM antibody, which has 10 binding sites, compared to conventional IgG antibodies with only 2 binding sites. We have created unique IgM antibodies with high selectivity, affinity, and avidity that may redefine what is possible for therapeutic antibody medicines. We believe our proprietary IgM antibody technology platform is particularly well suited for developing T cell engagers and receptor cross-linking agonists. The Company also has an exclusive worldwide collaboration agreement with Sanofi to create, develop, manufacture, and commercialize IgM antibody agonists against oncology, immunology, and inflammation targets. For more information, please visit www.igmbio.com.
IgM Antibodies and Autoimmune and Inflammatory Diseases
Antibody treatments have revolutionized outcomes for patients with autoimmune and inflammatory diseases. We are committed to exploring how our IgM antibody platform's unique structure and binding properties can improve outcomes for patients with these serious conditions.
IgM Antibodies and Oncology
The potential of our IgM antibodies drives our focus on oncology. Leveraging the power of avidity and the strong and durable binding of our IgM antibodies, we are developing new treatment options for cancer patients. Our initial efforts in this field are centered around the broad application of IgM antibodies to activate receptors, triggering the programmed death of cancer cells.
Position Description:
The Director of Regulatory Affairs will serve as the global regulatory lead (GRL) on several immunology programs and will be responsible for developing the global regulatory strategy in collaboration with key internal stakeholders, as well as tactical implementation of that strategy for IGM's growing pipeline of programs.
This position works cross-functionally with regulatory affairs and clinical development organizations to facilitate the completion of regulatory filing documentation according to company timelines. It also ensures adherence to relevant regulatory requirements and company Standard Operating Procedures (SOPs) as required.
Responsibilities:Develop and implement competitive and effective global regulatory strategies for various immunology products including clinical, nonclinical and CMC aspects and identify potential risks and mitigation strategies associated with proposed strategiesWork in close collaboration with the development team leader and other cross-functional colleagues, including CROs to deliver sound, efficient development strategies and operational plansLead and manage the development and preparation of high-quality global submissions (including IND, CTAs, BLAs, and MAAs) for IGM early and late-stage programs in collaboration with the regulatory and project teams to support and accelerate clinical development and regulatory approval.Represent Regulatory Affairs on assigned cross-functional development teams.Lead communication with global Health Authorities (HA), such as FDA and EMA, including, planning and preparing for formal meetings with regulatory agencies and interpreting HA feedback from these interactions.Provide updates on strategic global regulatory intelligence, such as new regulations, guidance, competitive product applications, approvals, and their impact on IGM programs.Anticipate issues and guide cross-functional teams on risk mitigation strategies for any development challenges.Qualifications:Level is commensurate with experienceMust have relevant immunology therapeutic area experience.A minimum of 10 years of Regulatory Affairs experience in the biopharma industry; Significant experience in the therapeutic area of immunology/autoimmunity is strongly preferredBS or higher degree in the life sciences; Advanced academic degree (Master’s or PhD) is a plusExperience as a GRL providing strategic regulatory advice to project teams for the global development of products through all stages of development.Extensive experience filing IND/CTAs and some experience with BLAs/NDAs/MAAsExtensive knowledge of regulatory requirements for all stages of drug development in a global environmentDemonstrated success in proactively managing collaborative relationships with key internal and external stakeholders, including FDA and other Health Authorities Proven ability to successfully lead regulatory meetingsAbility to work independently and to be innovative in tackling strategic and operational challengesExperience managing direct reports is preferredMust have strong verbal and written communication skillsMust be proficient with computer and standard software programs used in Regulatory AffairsWe offer a fast-paced, collaborative, team-based, work environment.
One of our top priorities is to maintain the health and well-being of our employees and their families. To achieve this goal, we offer comprehensive benefits with a variety of options:
· Medical, dental and vision insurance.
o The full premium amount for our employees and their dependents is covered by IGM
o FSA (Flexible Spending Account) or HSA (Health Savings Account)
· STD, LTD, Basic Life and AD&D Insurance, Supplemental Life and AD&D Insurance
o Voluntary Life Insurance and Disability
· 401(k) Plan with Employer Match
· 3 Weeks of Paid Time Off, 5 sick days per year, 12 holidays
· Cell phone & internet subsidy
· Employee Referral Bonus Program
· Annual training budget for professional development
· Commuter Benefit
· Annual bonus program
· New hire stock
o Annual refresh grants
· ESPP (Employee Stock Purchase Plan)
IGM is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status, and veteran status. All qualified applicants will receive consideration for employment.
